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Abstract
Background In a previous study of exposure to oil-related chemicals in Gulf coast residents, we measured blood levels of 
volatile organic compounds. Levels of styrene were substantially elevated compared to a nationally representative sample. 
We sought to identify factors contributing to these levels, given the opportunities for styrene exposure in this community. 
Methods We measured blood styrene levels in 667 Gulf coast residents and compared participants’ levels of blood styrene 
to a nationally representative sample. We assessed personal and environmental predictors of blood styrene levels using linear 
regression and predicted the risk of elevated blood styrene (defined as above the National Health and Nutrition Examination 
Survey 95th percentile) using modified Poisson regression. We assessed exposure to styrene using questionnaire data on 
recent exposure opportunities and leveraged existing databases to assign ambient styrene exposure based on geocoded 
residential location.
Results These Gulf coast residents were 4–6 times as likely as the nationally representative sample to have elevated blood 
styrene levels. The change in styrene (log ng/mL) was 0.42 (95% CI: 0.34, 0.51) for smoking, 0.34 (0.09, 0.59) for time 
spent in vehicles and 1.10 (0.31, 1.89) for boats, and −0.41 (−0.73, −0.10) for fall/winter blood draws. Residential 
proximity to industrial styrene emissions did not predict blood styrene levels. Ambient styrene predicted elevated blood 
styrene in subgroups.
Conclusions Personal predictors of increasing blood styrene levels included smoking, vehicle emissions, and housing 
characteristics. There was a suggestive association between ambient and blood styrene. Our measures of increased regional 
exposure opportunity do not fully explain the observed elevated blood styrene levels in this population.
Introduction
To address community concerns about exposure to poten-
tially harmful oil spill-related chemicals among Gulf coast
residents, we measured blood volatile organic compound
(VOC) levels in a subset of Gulf Long-Term Follow-up
Study (GuLF STUDY) participants 2–3 years after the
Deepwater Horizon (DWH) oil spill. We previously repor-
ted that blood levels of specific oil-related VOCs such as
benzene, toluene, ethylbenzene, and xylenes were similar
to those found in the National Health and Nutrition
Examination Survey (NHANES) [1]. Among the VOCs
included in the CDC-based test panel, only styrene was
substantially elevated. We further investigated styrene
levels due to increased exposure opportunity in the region.
Styrene, a hazardous air pollutant, is an established
neurotoxicant at occupational levels [2–4]. However, it has
not been studied at environmental levels experienced by the
general population. Styrene is used in plastics, fiberglass,
rubber and resins to manufacture building materials and
consumer products, such as fiberglass boats, automotive
parts, car tires, Styrofoam, and plastic drinking glasses [2].
The US produces over 12 billion pounds of styrene
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annually, with atmospheric emissions of 28 million pounds
per year [2, 5]. Environmental release of styrene from the
manufacture, use, and disposal of styrene-based products
occurs primarily through the air [6].
Emissions from industrial activities and motor vehicle
exhaust are the primary sources of styrene in outdoor air.
Ambient measurements of styrene typically show airborne
concentrations less than 1 part per billion by volume (ppb).
Rural or suburban air generally contains lower concentra-
tions of styrene than urban air [7], which is attributed
to increased motor vehicle emissions in urban areas [8].
Elevated ambient styrene concentrations are observed near
styrene-emitting industries, suggesting that individuals
living near manufacturing or processing facilities may
experience increased styrene exposure [2]. Ambient styr-
ene’s atmospheric lifetime is 1–2 days [2] and the half-life
of styrene in blood is approximately 13 h [3].
Indoor air styrene levels result primarily from tobacco
smoke, off-gassing of building materials and consumer
products, and emissions from photocopiers and laser prin-
ters [2]. Smoking is the single most important individual
predictor of human exposure to styrene [2, 9–15]. Exposure
to environmental tobacco smoke is also associated with
higher styrene exposure, particularly for nonsmokers living
with a smoker [11, 14]. Typically, indoor air contains
higher styrene levels than outdoor air [13].
Inhalation of contaminated air is the principal route of
styrene exposure for the general population [2], and the
main source of concern for health effects due to styrene
toxicity [16]. The highest styrene exposures generally occur
in the workplace, where styrene-exposed workers have
blood levels that are 25 times higher on average than those
in the general population [3, 17, 18]. Occupational exposure
to airborne styrene has been well-characterized among
reinforced plastics manufacturing workers [19–25].
The Gulf States are home to many styrene-emitting
industries and over half of all US styrene production [2, 26].
In addition to a prolific petrochemical industry, the Gulf
region is home to many industrial and manufacturing
facilities that use and emit styrene. This geographic clus-
tering of industries potentially exposes Gulf residents to a
disproportionately high intensity of environmental styrene
emissions.
Methods
Study design and participants
Approximately 2–3 years after the April 2010 DWH disaster
and oil spill, we took advantage of the ongoing enrollment
of participants in the GuLF STUDY to recruit individuals
living in the Gulf region for a sub-study of current blood
levels of VOCs [27]. The GuLF STUDY is a prospective
cohort of adults (ages 21 and older) who participated in oil
spill response activities and others who received safety
training but were not hired following the DWH disaster. A
detailed description of this study is available elsewhere [28].
As part of their participation in the sub-study, termed the
Chemical Biomonitoring Study (CBS), 994 individuals
provided blood specimen sufficient for quantification of
styrene levels. Because styrene is rapidly cleared from the
body and blood measurements were obtained 2–3 years
after the oil spill, these levels represent exposures occurring
around the time of sample collection (i.e., they are not due
to oil spill cleanup work).
In concert with ongoing home visits for the GuLF
STUDY we enrolled participants for the CBS between
September 2012 and May 2013. Eligible participants were
11,193 English- or Spanish-speaking individuals who
lived in Florida, Alabama, Mississippi, Louisiana, or eastern
Texas and participated in a home visit examination. CBS
participants were a convenience sample selected from
among GuLF STUDY participants whose home exams
were scheduled in the later months of study enrollment
and participation involved providing an extra blood
sample for measuring styrene and other compounds and
completing a questionnaire about usual and past 24-h
exposure opportunities. Study personnel geocoded partici-
pants’ residential locations using handheld global posi-
tioning system devices. We initially oversampled
nonsmokers and women, but because of timing of the
parent study, we ultimately invited all remaining eligible
participants to participate. Of the 994 individuals who
provided blood samples of sufficient quantity and quality
to measure styrene levels [29–31], 935 also had both a
measurement for the tobacco smoking biomarker 2,5-
dimethylfuran (2,5-DMF) and provided self-reported
smoking information. These 935 participants were inclu-
ded in analyses comparing blood VOC levels between the
CBS and the NHANES 2005–2008 [32, 33].
After we excluded participants who did not complete the
questionnaire on recent exposure opportunities (n= 125)
or were missing data on demographic factors (n= 142),
we restricted the remaining analyses to participants who
had complete information on all modeled predictors
(n= 667).
Participants provided written consent, and the Institu-
tional Review Board of the National Institute of Environ-
mental Health Sciences approved this study.
Exposure monitoring questionnaire
We collected demographic, socioeconomic, occupational,
lifestyle, and health information during the GuLF STUDY
enrollment and home visit interviews. CBS participants
additionally answered questions about potential contributors
to blood styrene levels. These included residential building
characteristics, self-reported proximity to industrial opera-
tions and waste sites (i.e., participants were asked to indi-
cate whether they lived within a half mile of each of the
following: major highways, a boatyard, docks, an oil
refinery, a petroleum storage or transfer facility, a gas sta-
tion, a factory, a power plant, a hazardous waste or
Superfund site, and a landfill), personal chemical exposures,
perceived air quality, drinking and bathing water source,
smoking and tobacco use, and hobbies and activities,
including exposure opportunities in the past 24 h (e.g.,
refueling vehicles or lawn equipment). We used an adapted
version of the Centers for Disease Control and Prevention
(CDC) NHANES 2007–2008 questionnaire [32] and US
Environmental Protection Agency Detroit Exposure and
Aerosol Research Study (DEARS) survey [34].
National emissions inventory
Point sources of styrene emissions were identified using the
2011 National Emissions Inventory Version 2 (NEI), the
United States Environmental Protection Agency’s (EPA’s)
latest comprehensive database of annual criteria, precursor,
and hazardous air pollutant emissions [35]. State, local, and
tribal air agencies report emissions sources, which are then
augmented with information from the Toxics Release
Inventory, the Acid Rain Program, and EPA’s regulatory air
toxics data.
We abstracted all records of reported styrene emissions
from the 2011 NEI point source database and mapped
participants’ home geocodes onto the locations of the NEI
point sources to calculate the distance between each parti-
cipant’s residence and proximal point sources. We assigned
exposure to point sources of styrene emissions based on
number of sources, linear distance to point source locations,
and volume of emissions at one-half, one, two, five, and
ten-mile buffers surrounding participants’ homes.
National Air Toxics Assessment
The EPA’s 2011 National-scale Air Toxics Assessment
(NATA) evaluates 180 air toxics across the United States
using emissions inventories, dispersion modeling, photo-
chemical modeling, exposure modeling, and toxicity ana-
lyses [36, 37]. NATA uses dispersion modeling to generate
annual average ambient air toxic concentrations for each
U.S. census tract. The model predicts the annual average
census tract concentrations for each major source type
(point, nonpoint, mobile), which are then summed to a total
concentration value for all source types combined. Styrene
concentrations in NATA 2011 arise from all three major
source types.
We employed NATA styrene estimates as indicators of
typical, long-term environmental exposure by mapping each
participant’s geocoded home location to a 2010 US census
tract, and applying the annual average total and source-
partitioned concentrations for that census tract to the
participant.
Blood collection and blood volatile organic
compound measurements
Glass blood collection tubes containing potassium oxalate
and sodium fluoride anticoagulant were used to collect
10 mL of blood for styrene measurement. Blood samples
were collected using tubes and stoppers that had been pre-
treated by the CDC laboratory to remove VOC residues to
minimize pre-collection contamination [38, 39]. Samples
were stored in a 4 °C refrigerator prior to being shipped
overnight on cold packs in biweekly batches to the Centers
for Disease Control and Prevention in Atlanta, Georgia
for analysis of VOCs. This laboratory conducts all
NHANES VOC analyses. Analysis of styrene followed the
standard CDC procedures for NHANES samples, using
equilibrium headspace solid-phase microextraction with
benchtop gas chromatography/mass spectrometry [29, 31],
allowing direct comparisons between measurements in CBS
and NHANES. 3 mL of blood was required per analysis.
We measured 2,5-dimethylfuran (2,5-DMF), a VOC
used as a smoking biomarker with comparable sensitivity
and specificity to serum cotinine (a well-validated
nicotine biomarker) [40]. Blood 2,5-DMF concentration of
0.014 ng/mL has been established as a threshold for dis-
tinguishing between current daily smokers (≥0.014 ng/mL)
and nonsmokers (<0.014 ng/mL) [15, 40], with the latter
comprising infrequent smokers whose blood styrene levels
have returned to that of nonsmokers. Unless otherwise
specified, we use this definition to identify smokers and
nonsmokers throughout all analyses.
Statistical analysis
We compared the distributions of blood styrene levels
measured in CBS participants (n= 935) to those observed
in NHANES participants ages 21 and older who had blood
styrene measured during the 2005–2006 and 2007–2008
NHANES cycles (N= 3958). All comparisons between
NHANES and CBS were stratified by the 2,5-DMF
threshold for smoking status (0.014 ng/mL). For compar-
isons to NHANES, we imputed blood styrene concentra-
tions below the limit of detection (LOD) as the LOD
divided by the square root of two [41], as is done in
NHANES. For all other statistical analyses, we used all
measured blood styrene values, including the actual values
below the LOD [42].
We also calculated the smoking-specific age- and sex-
standardized prevalence ratio of CBS participants with
blood styrene levels above the NHANES 95th percentile
standardized to the CBS sample. We presented this stan-
dardization approach without applying NHANES sampling
weights, but also conducted parallel analyses using
NHANES sampling weights to verify that the weighting
approach didn’t influence results. Styrene concentrations
were approximately log-normally distributed, so we used
natural logarithmically-transformed concentrations in con-
tinuous analyses.
For regression analyses, we further restricted to partici-
pants who completed the exposure monitoring questionnaire
(n= 810) and had complete covariate information for demo-
graphic factors, potential predictors, and ambient exposure
metrics (n= 667). We selected predictors a priori based
on previous literature [14, 43–48], with residential building
characteristics, lifestyle and behaviors, recreational and
occupational activities, and relevant recent exposures as
candidate predictors. We additionally considered ambient
styrene predictors, including NATA total and source-
partitioned (point, nonpoint, and mobile) concentrations as
well as NEI point source emissions of styrene. Metrics of
emissions included binary indicators (presence or absence
of sources), number of sources, and distance- and volume-
weighted intensity of sources surrounding participants’
homes. We used analysis of variance and t-tests to prioritize
candidates based on the strength and statistical significance
of their unadjusted relationship with blood styrene levels.
We implemented a predictive modeling approach using
least squares regression aimed at maximizing the model
adjusted R2 and retained covariates with p-values <0.10.
We chose this approach because many sources of styrene
exposure were rare in this population. We maintained
a statistical significance threshold of α= 0.05, and report
the change in log-styrene concentration (β coefficient)
attributed to each predictor, and its associated 95% con-
fidence interval and p-value.
We also used multivariable regression to estimate pre-
valence ratios and corresponding 95% confidence intervals
(PR, 95% CI) for a blood styrene measurement exceeding
the smoking-specific NHANES 95th percentile. Due to model
convergence problems for the log-binomial model, all ana-
lyses were completed using a modified log-binomial approach
with a Poisson distribution [49]. The same predictive
modeling approach described for the analysis of continuous
styrene was used to specify the modified Poisson model.
Due to concerns about varying data reporting and
quality of NATA estimates between states, we evaluated
agreement between NATA modeled ambient styrene con-
centrations and observed styrene concentrations from EPA
Ambient Monitoring Archive (AMA) monitors in the
study region. We compared annual average monitored
concentrations to corresponding census tract NATA estimates
for each state. Lacking sufficient sample size to conduct
individual state regression analyses, we conducted sensitivity
analyses excluding one state at a time to evaluate the influ-
ence of state reporting differences on the association between
NATA exposure data and elevated blood styrene levels.
To more efficiently examine ambient predictors of
elevated blood styrene (i.e., NATA and NEI exposures),
we identified a subgroup with no tobacco smoke-related
styrene exposure (n= 300) by restricting to participants
with blood 2,5-DMF <0.014 ng/mL and removing an
additional 97 individuals who reported any active or passive
tobacco smoke exposure in the past 24 h. We further
restricted to participants living in states where NATA best
reflected observed AMA concentrations (n= 224), and
removed individuals with spring blood draws to account
for seasonal differences in ambient styrene, resulting in a
sample of 195 participants. We then used the same modified
Poisson model to estimate associations between ambient
exposures and blood styrene exceeding the NHANES
95th percentile in this subgroup.
All statistical analyses were conducted in SAS 9.4
(Cary, NC, USA) and spatial analyses were completed
in Esri ArcGIS Desktop 10.3 (Redlands, CA, USA).
Results
Blood styrene levels for these CBS participants (n= 935)
were two to three times higher than those reported in
NHANES (n= 3958) (Table 1) for both smokers and
Table 1 Blood styrene levels in the CBS (n= 935) and NHANES
(2005–2008) (n= 3958)
Nonsmokersa Smokersb
CBS NHANES CBS NHANES
N 551 3,137 384 821
Percent detect 61.9 23.7 99.2 96.1
Mean 0.26 0.03 0.34 0.11
Geometric mean 0.07 0.03 0.15 0.07
25th percentile <LOD <LOD 0.07 0.06
Median 0.04 <LOD 0.12 0.09
75th percentile 0.08 <LOD 0.28 0.13
95th percentile 1.67 0.06 1.62 0.23
Maximum 4.81 4.10 4.58 0.78
Blood styrene concentration measured in ng/mL. Limit of detection
(LOD)= 0.03 ng/mL. Values below the LOD are imputed as
LOD / √2= 0.02 ng/mL
aNonsmokers defined as having blood 2,5-dimethylfuran <0.014 ng/mL
bSmokers defined as having blood 2,5-dimethylfuran concentration
<0.014 ng/mL
nonsmokers, but considerably lower than levels typically
observed among occupationally exposed populations.
Among nonsmokers, detection rates were considerably
higher in CBS (61.9%) than NHANES (23.7%). Among
smokers, rates were more comparable between study
populations (CBS, 99.2%; NHANES, 96.1%). The dis-
tribution of blood styrene in CBS is right-skewed, regard-
less of smoking status. Nonsmokers in CBS were almost six
times as likely to have elevated blood styrene (blood mea-
surement above the NHANES 95th percentile), and smokers
in CBS were more than four times as likely to have elevated
blood styrene, as their NHANES counterparts (Fig. 1). The
apparent second peak in the blood styrene distributions
above the NHANES 95th percentile for both smokers and
nonsmokers in CBS suggests that an elevated styrene
measurement may indicate membership in a subgroup with
a higher mean exposure distribution.
Overall, two-thirds of CBS participants included in pre-
dictor models (n= 667) are younger than 50, three-fourths
are male, half are white, and three-fourths are overweight
or obese (Table 2). Most participated in oil spill cleanup
work (85.8%), and over half are unemployed. Approxi-
mately 40% of modeled CBS participants had blood 2,5-
dimethylfuran levels characteristic of smoking. Smokers
tended to be younger, less educated, more likely to be
nonwhite, and have lower body mass index. They were also
more likely than nonsmokers to report lower income and
unemployment.
We identified several predictors of blood styrene levels
(Fig. 2), though the overall model adjusted R2 was 0.19.
Continuous log-transformed blood 2,5-dimethylfuran level
was a strong predictor of increasing blood styrene level
(β, 0.42 log ng/mL; 95% CI: 0.34, 0.51), demonstrating
the importance of smoking as a styrene exposure source
(Supplemental Table 1). Living in a home painted in the
past six months (n= 82; β, −0.46 log ng/mL; 95% CI:
−0.75, −0.17) was associated with lower styrene levels,
while concrete/cinderblock (n= 169; β, 0.37; 95% CI: 0.11,
0.64) and wood (n= 265; β, 0.35; 95% CI: 0.13, 0.57),
home exteriors predicted higher blood styrene levels. Other
significant predictors of increasing styrene included boating
in the Gulf in the past 24 h (n= 10; β, 1.10; 95% CI: 0.31,
1.89), spending at least three hours in motor vehicles in the
past 24 h (n= 122; β, 0.34; 95% CI: 0.09, 0.59), living in a
Fig. 1 Prevalence ratio of blood styrene concentrations exceeding the
smoking-specific NHANES 95th percentile in the CBS compared to
NHANES (n= 935). Solid line indicates CBS study; black shading
indicates CBS study 95th percentile. Dashed line indicates NHANES;
gray shading indicates NHANES 95th percentile. NHANES 95th
percentile: nonsmokers, 0.06 ng/mL; smokers, 0.23 ng/mL. PR, pre-
valence ratio (95% confidence interval)
Table 2 Characteristics of participants with blood styrene








N % N % N %
Age (years)
<30 123 18.4 59 21.9 64 16.1
30–50 325 48.7 138 51.1 187 47.1
>50 219 32.8 73 27.0 146 36.8
Body Mass Index (kg/m2)
<25 159 23.8 89 33.0 70 17.6
25–30 200 30.0 75 27.8 125 31.5
>30 308 46.2 106 39.3 202 50.9
Education
<High school graduate 128 19.2 66 24.4 62 15.6
High school graduate 249 37.3 109 40.4 140 35.3
>High school graduate 290 43.5 95 35.2 195 49.1
Race
Black 277 41.5 133 49.3 144 36.3
White 336 50.4 118 43.7 218 54.9
Other 54 8.1 19 7.0 35 8.9
Sex
Female 164 24.6 57 21.1 107 27.0
Male 503 75.4 213 78.9 290 73.0
Timing of blood draw
Fall/Winter 597 89.5 244 90.4 353 88.9
Spring 70 10.5 26 9.6 44 11.1
Work status
Employed 374 43.9 116 43.0 258 65.0
Unemployed 293 56.1 154 57.0 139 35.0
Oil spill cleanup work
≥1 day 572 85.8 242 89.6 330 83.1
None 95 14.2 28 10.4 67 16.9
Annual income
< $20,000 275 41.2 140 51.9 135 34.0
$ 20,000–$50,000 230 34.5 93 34.4 137 34.5
>$50,000 162 24.3 37 13.7 125 31.5
aSmokers defined as having blood 2,5-dimethylfuran concentration
≥0.014 ng/mL; nonsmokers, blood 2,5-dimethylfuran <0.014 ng/mL
mobile home, RV, or boat (n= 99; β, 0.35; 95% CI: 0.07,
0.63), and reporting recreational fishing (n= 330; β, 0.20;
95% CI: 0.0002, 0.39). Being employed (n= 374; β= 0.19;
95% CI: −0.01, 0.38) was a positive predictor of blood
styrene, of borderline significance. Blood draws in fall or
winter (n= 597; β, −0.41; 95% CI: −0.73, −0.10) were
associated with lower blood styrene levels, compared to
spring blood draws. Ambient nonpoint styrene concentra-
tions were weakly and non-significantly predictive of
increasing blood styrene levels, with the strongest associa-
tion in the second quartile. State of residence was non-
significantly associated with blood styrene levels, with
Florida residents (n= 165) having the highest blood styrene
levels (β, 0.27; 95% CI: −0.07, 0.61). Predictors of elevated
blood styrene (when defined as above the NHANES 95th
percentile) in the overall sample were similar in magnitude
and direction to the observed predictors of continuous blood
styrene (Supplemental Fig. 1).
We identified a subgroup to more efficiently assess
ambient, as opposed to personal, predictors of styrene. The
subgroup was defined as those unexposed to tobacco smoke
(active or passive), with fall or winter blood draw, and
not living in Alabama. Predictors of elevated blood styrene
(above the NHANES 95th percentile) among these partici-
pants included ambient nonpoint styrene concentration
and Florida residence (Fig. 3). We excluded Alabama based
on results of a sensitivity analysis examining associations
between NATA estimated concentrations and AMA
observed concentrations by state (Appendix I). Using the
limited data available, we determined that Alabama
demonstrated appreciably less agreement with observed
concentrations than the four remaining states. In this sub-
group analysis, we observed a weak increasing exposure-
response relationship across quartiles of ambient nonpoint
styrene concentration, where participants in the highest
exposure group were twice as likely to have elevated
blood styrene as those in the lowest group (PR, 2.1; 95%
CI: 1.0, 4.4). Florida residents were twice as likely to
have elevated blood styrene as their counterparts from
Mississippi (PR, 2.0; 95% CI: 1.1, 3.7). Exposure to point
source emissions of styrene was not associated with ele-
vated blood styrene levels for any of the exposure metrics
or spatial scales we examined (data not shown).
Discussion
We conducted this study to characterize blood styrene levels
among Gulf coast residents and identify determinants of
styrene exposure. Blood styrene levels among CBS parti-
cipants were substantially elevated compared to NHANES,
particularly in the upper tail of the distribution. These
levels, while higher than NHANES, are orders of magnitude
lower than occupational exposure levels. Participants living
in Florida had the highest blood styrene levels. Personal, as
well as environmental factors, predicted blood styrene
levels in the overall CBS sample. In a subgroup identified to
facilitate examination of environmental factors, ambient
styrene from nonpoint sources was associated with elevated
blood styrene with a suggestive exposure-response rela-
tionship. However, proximity to industrial styrene emis-
sions from point sources was not related to blood styrene.
Fig. 2 Predictors of blood styrene levels (n= 667). Blood 2,5-DMF
(log), log-transformed blood 2,5-dimethylfuran concentration. NATA
nonpoint, National Air Toxics Assessment 2011 annual average cen-
sus tract ambient styrene concentration attributable to nonpoint sour-
ces. Q1, First quartile; Q2, Second quartile; Q3; Third quartile; Q4,
Fourth quartile. State, participant’s state of residence
Fig. 3 Predictors of blood styrene measurement >NHANES 95th per-
centile among participants unexposed to tobacco smoke* with fall/
winter blood draws, not living in Alabama (n= 195). *Unexposed to
tobacco smoke: jointly defined as having blood 2,5-dimethylfuran
<0.014 ng/mL and reporting no active or passive smoke exposure in
the 24 h preceding blood collection. NATA nonpoint, National Air
Toxics Assessment 2011 annual average census tract ambient styrene
concentration attributable to nonpoint sources. Q1, First quartile; Q2,
Second quartile; Q3; Third quartile; Q4, Fourth quartile. Point sources,
National Emissions Inventory 2011 point source emitters of styrene
within 1 mile of participant’s geocoded home location. Florida,
Louisiana, Mississippi, participant’s state of residence
Although several different environmental, behavioral,
and social factors have been identified as determinants of
styrene exposure, these factors typically explain less than
25% of the variance in measured styrene exposure [8, 14].
In our study, smoking, spending time in boats or vehicles in
the past 24 h, recreational fishing, being employed, and
living in mobile housing were positively associated with
blood styrene levels. Living in a home painted in the past
six months and fall/winter blood draws were inversely
associated with blood styrene levels.
We observed a highly significant, precise, positive asso-
ciation between the biomarker for smoking (2,5-dimethylfuran)
and blood styrene. Previous studies indicate that smokers have
blood styrene levels approximately fourfold higher than those
of nonsmokers [2, 10, 13–15, 50–53]. Although cigarettes are
considered the dominant source of styrene exposure among
smokers, environmental tobacco smoke contributes only about
8% of nonsmokers’ exposure [12].
Spending at least three hours in a vehicle or any time in a
boat in the Gulf of Mexico in the past 24 h were both
associated with increasing styrene levels. Likewise,
recreational fishing was a predictor of styrene exposure.
These predictors likely confer increased styrene exposure
from combustion engine emissions, an established source of
outdoor styrene exposure [8, 12, 54, 55].
The association between employment and increasing
blood styrene suggests that sources outside the home could
be driving higher exposures in nonsmokers [54]. We con-
ducted a preliminary analysis of reported occupation,
industry, and main job activities to ascertain styrene-related
occupational exposure opportunities. We determined that
such opportunities were too rare in our population (<0.1%)
to account directly for the association between employment
status and blood styrene.
Participants who reported living in mobile housing had
higher blood styrene levels. This association may reflect
housing materials with more off-gassing than other types of
residences, or lower air exchange rates resulting in higher
indoor styrene levels [56]. Mobile housing is likely to be
smaller than apartments, townhouses, and detached homes,
with fewer rooms and windows. Previously, smaller house
size and lower number of windows have been associated
with increased styrene exposure [54].
Blood styrene levels are fairly consistent within season,
though monitoring suggests significantly lower ambient
styrene levels in the spring compared to all other seasons
[57]. We observed lower blood styrene levels in fall and
winter compared to spring, however the seasonal distribution
of blood collection (90% in fall or winter) precluded
seasonally-stratified analyses and further exploration into
this relationship. We did not observe correlations between
ambient and blood styrene levels, so the discrepancy with
previously reported monitored data is not entirely surprising.
Previous research suggests that individuals living near
styrene manufacturing or processing facilities may experi-
ence increased exposure from point source emissions,
totaling 47.3 million pounds annually in the US [2]. Resi-
dential proximity to styrene-emitting industrial facilities has
been shown to confer up to 15 ppb of annual average
styrene exposure [58] with elevated concentrations detected
up to 10 kilometers away [59]. In our analyses, however,
styrene levels varied independently of residential proximity
to point source emissions, with no relationship to volume,
intensity, distance, or type of emission source at a range of
buffers from 0.5 miles to 10 miles. Similarly, NATA esti-
mated concentrations attributable to point sources were not
associated with blood styrene levels. Our measures of
exposure to point source emissions may be insufficient to
capture episodic exposure scenarios, as both data sources
rely on annual reporting. These measures fail to reflect
seasonality or temporal variability that may influence the
prediction of a single blood draw. Because national-scale
ambient styrene monitoring is limited, with poor spatial and
temporal coverage, we were unable to evaluate monitored
styrene concentrations in association with contemporaneous
blood styrene levels.
We evaluated total NATA concentrations, as well as
source-partitioned values for each major source type. Total,
point, and mobile concentrations were not associated with
styrene levels in the full study population. However, when
we looked in the subgroup identified to better examine
environmental sources of elevated blood styrene, NATA
nonpoint styrene concentration showed a positive exposure-
response relationship. This association only emerged among
nonsmokers with no reported environmental tobacco smoke
exposure, who had fall/winter blood draws, and did not live
in Alabama. We selected this group to reduce other major
sources of styrene variability and measurement error so that
we could better assess the relationship between ambient and
blood styrene. Improving the signal to noise ratio in this
way did allow us to detect an association that was not
apparent in the main analysis.
Nonpoint sources are smaller sources or sources related
to residential activity (residential wood combustion, con-
sumer, and commercial solvent usage, etc.), which are
inventoried at the county level, and subsequently allocated
to census tracts. These types of styrene exposure sources
may demonstrate more temporal consistency within seasons
than point source emissions, and therefore be more relevant
predictors of spot blood styrene levels than sources which
vary episodically. Reporting for nonpoint sources may also
be more reliable than other major source types, so that
modeled concentrations are a more accurate representation
of nonpoint exposures than other source types.
The primary strength of our study is the examination of
both indoor and outdoor predictors of internal burden of
blood styrene in a population with elevated blood styrene
levels. While other studies have typically prioritized either
indoor or outdoor styrene sources, our study includes
detailed self-reported characterization of indoor exposure
opportunities and conditions, as well as two different
assessments of outdoor styrene levels and sources.
We also used an established biomarker of internal styr-
ene body burden, with a detailed, previously validated
questionnaire capturing the relevant timing for the blood
measurement [34]. This recall period, 24 h, was sufficiently
short to minimize the risk of recall bias and matched
the styrene elimination half-life of approximately 13 h. We
ascertained smoking using a validated biomarker and sup-
plemented with self-reported information on environmental
tobacco smoke in sensitivity analyses. Blood styrene and
2,5-dimethylfuran levels in both CBS and NHANES were
analyzed in the same laboratory, using the same methods,
which permit quantification of general population exposure
levels [29]. Geocoding participants’ residential locations
allowed for a variety of flexible spatial analyses incorpor-
ating distance decay with point source emissions. Finally,
our study was carried out in an understudied population that
has been frequently exposed to multiple natural and man-
made disasters, and lives in a region with enhanced indus-
trial styrene exposure opportunity.
Repeated biomarker measurements may provide a more
reliable estimate of usual exposure than the single blood
specimen obtained in our study, particularly because of the
rapid elimination of styrene from the body. Given the half-
life of styrene in blood, blood levels reflect only exposures
experienced within the past 12–24 h.
Occupational data were reported at enrollment and
potentially not reflective of the 24-h exposure window
preceding the blood draw. Despite this limitation, it is
unlikely that occupational styrene exposure is influencing
blood styrene levels in this study population because
styrene-related occupations tend to be highly specific and
were reported rarely among CBS participants. Candidate
occupations we considered included: working in a fiberglass
reinforced plastic or cultured marble factory, fiberglass boat
building or repair, manufacturing styrene resin, polymer,
rubber, or styrene-butadiene rubber tires, manufacturing
fiberglass wind turbines, and relining sewer lines with
styrene-based resin pipe.
Reporting to the NEI database is voluntary and designed
for regulatory purposes. As such, the quality of the data and
availability of information for our intended investigation
may not be ideal. These data are limited to annual aggregate
values and lack any temporal specificity. Similarly, the
NATA estimates are annual averages derived from volun-
tarily reported inputs, the protocols for which vary between
states. Although imperfect, in the absence of sufficient
monitoring data, these data sources provide the best
available outdoor exposure information for a study of our
scope and purpose.
The modestly elevated blood styrene levels among CBS
participants created a unique opportunity to assess a range
of environmental styrene exposures. Although we were
only able to account for approximately 20% of the varia-
bility in styrene exposure, this is consistent with what other
studies have achieved when attempting to predict blood
VOC levels [45, 50]. We identified several personal pre-
dictors of blood styrene, which were largely consistent with
what has been published previously. Despite intense
styrene-related industrial activity across the study region,
we did not observe any relationship between proximity to
point source styrene emissions and blood styrene. Rather,
our results suggest that, at least among individuals without
appreciable tobacco smoke exposure, exposure from non-
point sources may be an important predictor of blood
styrene levels. Future research in this area would benefit
from repeated measures of blood styrene, as well as tem-
porally specified environmental styrene sources, whether
through monitoring or improved modeling.
Acknowledgements We thank Mark Bodkin for data management on
this project. We also thank Cindy Hines for her expertise on occu-
pational exposure, and David Chambers for blood VOC measurement.
Funding This work was funded by the NIH Common Fund and the
Intramural Program of the NIH, National Institute of Environmental
Health Sciences (Z01 ES 102945).
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Appendix I Evaluation of National Air Toxics
Assessment by state
Owing to concerns about inter-state variability in NATA
data quality and reporting, we examined agreement between
NATA estimates and monitored concentrations in corre-
sponding census tracts by state (Table A1). Treating the
annual average of observed values at monitors as the true
estimate of exposure at that location, NATA performance is
best in Louisiana and Texas, followed by Mississippi and
Florida. Alabama emerged as potentially problematic based
on the large disparity with monitored data. Estimated con-
centrations in Alabama are furthest from monitored con-
centrations, with a marked difference from the other Gulf
states. This analysis is very limited by the sparsity of
monitoring coverage, but given the general lack of data
availability, we felt that any additional information con-
tributed to our evaluation.
Based on the patterns observed in Table A1, we exam-
ined effects of differential reporting to NATA by state on
associations between ambient and blood styrene levels.
Given insufficient sample sizes in each individual state to
support state-specific analyses, we instead conducted four
parallel analyses eliminating one state each time (Fig. A1).
Results were fairly consistent across analyses, apart from
the removal of Alabama. When participants from Alabama
were excluded, we observed an association between non-
point ambient exposure and elevated blood styrene.
We hypothesized that NATA data may represent differ-
ent underlying information in Alabama, as compared with
the other Gulf states. We used this information to select
a subpopulation in which we had higher confidence in
NATA data, ultimately excluding participants from Ala-
bama for sensitivity analyses that were focused on NATA
estimates of exposure.
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